All Microbial Biotechnology articles – Page 3
-
NewsScottish biotech company Lentitek secures £1m funding to advance next generation cancer treatments
Biotech company Lentitek Ltd has secured £700,000 in private funding from Equity Gap, bringing its total investment to £1 million in the last six months. It develops manufacturing technologies for lentiviral vectors, used with CAR-T cell and gene therapies.
-
NewsResearchers reveal key mechanism behind bacterial cancer therapy
A research team has elucidated the mechanism behind bacterial cancer therapy using a genetically engineered bacterial strain.
-
NewsNewly launched Enodia Therapeutics is a biotech company with a new approach for targeted protein degradation
Argobio and the Institut Pasteur have announced the launch of Enodia Therapeutics, a groundbreaking French biotech company dedicated to block and degrade disease-causing proteins for treating cancer, inflammatory diseases and viral infections.
-
NewsScottish bio-tech company secures £3.4m investment
Scottish biotech engineering company uFraction8 has secured £3.4m in new investment following the completion of a funding round led by Foresight Group.
-
NewsBacteria evolved to help neighboring cells after death, new research reveals
A study has shown that a type of E coli bacteria produces an enzyme which breaks the contents of their cells down into nutrients after death. The dead bacteria are therefore offering a banquet of nutrients to the cells that were their neighbours when they were living.
-
NewsScientists recode the genome for programmable synthetic proteins
Synthetic biologists were able to re-write the genetic code of an organism — a novel genomically recoded organism (GRO) with one stop codon — using a cellular platform that they developed enabling the production of new classes of synthetic proteins.
-
NewsFirst success in overcoming gene therapy challenges deploys nanomachines loaded with wine ingredients
Scientists have demonstrated the ability to overcome significant challenges in gene therapy using adeno-associated virus vectors (AAV) by employing a novel smart nanomachine equipped with AAV.
-
FeaturesFrom Earth to space - exploring fungi in extraterrestrial environments
Fungi are incredible organisms in terms of plasticity, resilience, and adaptation. However, they have the potential to both help and hinder us.
-
CareersThe true cost of science
Discover valuable insights from three companies in the microbiology field, and their experience of balancing innovation, investment, and sustainability to drive their success.
-
NewsCARB-X funds Melio to develop rapid diagnostic to detect neonatal sepsis
CARB-X will award biotechnology company Melio US$3.5M to develop and execute a technical feasibility workplan for its culture-free platform designed to identify blood stream infections including neonatal sepsis.
-
CareersLetters in Applied Microbiology: Racheal reflects on a year in the junior editor programme
One year into our first junior editor training programme with Letters in Applied Microbiology, Racheal Oluwayemisi Fashogbon reveals how signing up has helped to transform her career.
-
CareersTowards space plastics - and solving a few Earth problems en route
Dr Nils Averesch, Assistant Professor of Space Biology at the Space Life Science Laboratory, Cape Canaveral, reveals how his research on microbial plastic production could pave the way for thriving human settlements in space.
-
CareersThe Space Microbiology Group
The Space Microbiology Group studies how microorganisms behave in space conditions, using tools such as microbiology, molecular biology, system biology and geomicrobiology to learn how new biotechnologies could be applied to space.
-
FeaturesNature’s pesticides: unleashing the potential of microbial interactions
Discover how scientists leverage knowledge of the microbial interactions that impact plant and animal health.
-
NewsApplication of heavy-ion irradiation mutagenesis to improve the production efficiency of the antifungal drug micafungin
Scientists have used heavy-ion irradiation to improve efforts to produce the semisynthetic echinocandin antifungal agent micafungin which derives from fungal natural product FR901379 produced by Coleophoma empetri.
-
NewsScientists offer user manual for yeast’s genetic switches
Scientists have found three gene regulation design principles that provide a flexible guideline for the effective control of microbiological production using yeast.
-
NewsBioengineered yeast microbes as targeted drug delivery systems
Researchers from the Yong Loo Lin School of Medicine (NUS Medicine) have developed a groundbreaking way to engineer yeast (Saccharomyces cerevisiae) to create microbial communities that can perform complex tasks and self-regulate their composition in response to external signals. Source: Alexander Klepnev Baker’s yeast cells. Calcofluor ...
-
NewsResearchers develop light-guided siRNA delivery system based on cyanobacteria
In a study published in Cell Reports Physical Science on Nov. 25, a research team led by Prof. Cai Lintao from the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences reported its development of an innovative intelligent light-guided biohybrid system, the CTPA/siCSF1R system, to target tumor-associated ...
-
NewsWomen’s health company Freya Biosciences announces key $10.4m strategic investment
Freya Biosciences, a transatlantic biotech company specializing in women’s health, has announced a major strategic investment which will be used to develop microbial immunotherapies for the treatment of bacterial vaginosis.
-
NewsFunding boost to bring engineering biology technologies to market
Part of a £2.8 million UKRI seed corn fund has been awarded to the Environmental Biotechnology Innovation Centre (EBIC) to bridge the gap between research and market-ready products and technologies, with comprehensive support and resources for researchers.